Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Download original image
Fig. 3. Forest plots showing post-treatment differences between buspirone and placebo in individual upper gastrointestinal symptoms: (A) bloating severity, (B) postprandial fullness, and (C) nausea severity. REML, restricted maximum likelihood.
J Neurogastroenterol Motil 2025;31:18~27 https://doi.org/10.5056/jnm24115
© J Neurogastroenterol Motil